Monitoring tafamidis treatment with quantitative SPECT/CT in transthyretin amyloid cardiomyopathy

AIMS: Tafamidis treatment positively affects left ventricular (LV) structure and function and improves outcomes in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). We aimed to investigate the relationship between treatment response and cardiac amyloid burden identified by serial quantit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rettl, René, Wollenweber, Tim, Duca, Franz, Binder, Christina, Cherouny, Bernhard, Dachs, Theresa-Marie, Camuz Ligios, Luciana, Schrutka, Lore, Dalos, Daniel, Beitzke, Dietrich, Loewe, Christian, Badr Eslam, Roza, Kastner, Johannes, Hacker, Marcus, Bonderman, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364619/
https://www.ncbi.nlm.nih.gov/pubmed/36881774
http://dx.doi.org/10.1093/ehjci/jead030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364619/
https://www.ncbi.nlm.nih.gov/pubmed/36881774
http://dx.doi.org/10.1093/ehjci/jead030

Ejemplares similares